Combination activity of eribulin liposomal formulation and anti-PD-1 antibody after tumor regrowth during anti-PD-1 antibody treatment in mice

被引：0
|
作者：
Tamura, Moe
Niwa, Yuki
Semba, Taro
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5260
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5260
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Robust anti-tumor effects of combined anti-CD4 depleting antibody and anti-PD-1/PD-L1 immune checkpoint antibody treatment in mice
    Ito, Satoru
    Matsushima, Kouji
    Ueha, Satoshi
    Yokochi, Shoji
    Ishiwata, Yoshiro
    Hachiga, Kosuke
    Ogiwara, Haru
    Chand, Krishant
    Nakajima, Takumi
    CANCER RESEARCH, 2015, 75
  • [22] Preclinical combination strategies to enhance the efficacy of the anti-PD-1 antibody pembrolizumab
    Pinheiro, Elaine M.
    Hinton, Marlene
    Mangadu, Ruban
    Cai, Mingmei
    Phan, Uyen
    Nebozhyn, Michael
    Hirsch, Heather
    Loboda, Andrey
    Javaid, Sarah
    Wang, Yaolin
    Sriram, Venkataraman
    Phillips, Joseph H.
    McClanahan, Tern
    Long, Brian
    CANCER RESEARCH, 2016, 76
  • [23] Growth arrest of a refractory vestibular schwannoma after anti-PD-1 antibody treatment
    Martinez, Frank Kouzel
    Graffeo, Christopher Salvatore
    Carlstrom, Lucas P.
    Link, Michael J.
    BMJ CASE REPORTS, 2021, 14 (05)
  • [24] A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity
    Albu, Diana I.
    Wolf, Benjamin J.
    Qin, Yan
    Wang, Xianzhe
    Ulumben, Amy Daniel
    Su, Mei
    Li, Vivian
    Ding, Eirene
    Gonzalo, Jose Angel
    Kong, Jason
    Jadhav, Ruturaj
    Kuklin, Nelly
    Visintin, Alberto
    Gong, Bing
    Schuetz, Thomas J.
    ONCOIMMUNOLOGY, 2024, 13 (01):
  • [25] In vivo characterization of inhibitory anti-PD-1 antibody superagonists
    Akkaya, B.
    Davis, S. J.
    Cornall, R. J.
    IMMUNOLOGY, 2011, 135 : 44 - 44
  • [26] Amlexanox enhances the antitumor effect of anti-PD-1 antibody
    Takeda, Kazuhiko
    Yano, Koji
    Yamada, Kaoru
    Kihara, Akio
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 560 : 1 - 6
  • [27] Lenvatinib enhances antitumor immunity of anti-PD-1 antibody
    Kato, Yu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2025, : 666 - 673
  • [28] Acute Lymphocytic Myocarditis With Anti-PD-1 Antibody Nivolumab
    Tadokoro, Tomonori
    Keshino, Eri
    Makiyama, Akitaka
    Sasaguri, Takakazu
    Ohshima, Koichi
    Katano, Harutaka
    Mohri, Masahiro
    CIRCULATION-HEART FAILURE, 2016, 9 (10)
  • [29] Innovative cancer immunotherapy, anti-PD-1 antibody Nivolumab
    Shibayama, Shiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S40 - S40
  • [30] ENHANCED ANTI-TUMOR EFFECTS OF ANTI-CTLA-4 ANTIBODY AND ANTI-PD-1 ANTIBODY TO KIDNEY CANCER MODEL IN MICE
    Motoshima, Takanobu
    Komohara, Yoshihiro
    Hasita, Horlad
    Kawano, Yoshiaki
    Wada, Yoshihiro
    Takeya, Motohiro
    Eto, Masatoshi
    JOURNAL OF UROLOGY, 2014, 191 (04): : E372 - E373
12345